Titlebook: Cost Versus Benefit in Cancer Care; Basil A. Stoll (Honorary Consulting Physician) Textbook 1988Latest edition The Editor and the Contribu

duplicate

執(zhí)

pus840

Gebhard Kirchg?ssner,Bruno S. Freyrom the society at large that are utterly unrealistic on a day-to-day basis. They are asked to be Renaissance men and women in an age when that is no longer possible; they are expected to be ultimate healers, technological wizards, total authorities. (When a physician refuses to accept those expecta

MAL

Jürgen W. Falter,Siegfried Schumannncer. Most practitioners in the UK feel that their prime duty is to the individual patient, and only secondarily to the economic consequences of their actions. The British primary care physician is thus free to refer the patient with cancer to any of the local hospital consultants who in turn, have

小平面

Wilhelm Bürklin,Russell J. Daltonresearch now proceeds through various ‘phases’ and this process is regarded as critical to the development of new forms of treatment. To measure the costs and benefits of clinical cancer research is complex, and must be tackled from the perspective of society as well as from that of the individual p

拘留

Wilhelm Bürklin,Russell J. Daltonlness are much more open than they were 10 years ago. Discussions of ethical dilemmas about life-sustaining treatment and about terminal care are frequent in medical journals and in the lay press. Most hospitals have medical staff policies about ‘do not resuscitate’ orders, and many hospitals have e

憎惡

ARY

SPECT

adroit

vestigation, and among professionals about indefinite struggles to maintain life in moribund patients. Because of its emotional overtones, public discussion tends to be muted in the case of cancer, but physicians are well aware of gross contrasts between Europe and the USA in the aggressiveness of m